JPMORGAN CHASE & CO - AVALO THERAPEUTICS INC ownership

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of AVALO THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$1,000
-95.2%
1,848
-93.7%
0.00%
Q1 2022$21,000
-74.7%
29,233
-39.7%
0.00%
Q4 2021$83,000
+88.6%
48,519
+137.8%
0.00%
Q3 2021$44,00020,4010.00%
Other shareholders
AVALO THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 45,000,000$98,100,0001.66%
Integral Health Asset Management, LLC 1,625,000$3,543,0001.02%
Stonepine Capital Management, LLC 850,000$1,853,0000.84%
Asymmetry Capital Management, L.P. 534,621$1,165,0000.70%
Opaleye Management Inc. 1,459,400$3,181,0000.59%
Nantahala Capital Management 6,952,401$15,156,0000.48%
Ikarian Capital, LLC 718,705$1,566,0000.11%
Monashee Investment Management LLC 270,000$589,0000.11%
BOOTHBAY FUND MANAGEMENT, LLC 1,204,930$2,627,0000.07%
Point72 Asset Management, L.P. 6,008,850$13,099,0000.06%
View complete list of AVALO THERAPEUTICS INC shareholders